Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

What fueled the previous growth in the impetigo market?

The market size for impetigo has experienced robust expansion in recent times. It is anticipated to escalate from $2.25 billion in 2024 to $2.41 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 7.0%. This growth during the historical phase can be credited to the increasing number of skin infection cases, enhancements in healthcare infrastructure, broader access to telemedicine, a rise in public financial support for infectious diseases, in addition to the surging demand for topical treatments.

What will be the impetigo market size in the future?

The market for impetigo is predicted to witness substantial potential for growth in the subsequent few years, expanding to $3.11 billion in 2029 with a compound annual growth rate (CAGR) of 6.6%. The notable growth during the forecast period can be owed to factors such as the evolution of telemedicine and E-pharmacy, initiatives from both, the government and private sector, increasing instances of skin infections, and the surge in the pediatric population along with the escalating demand for dermatology clinics. Key trends during this forecast period encompass advancements in topical treatments, introduction of innovative antimicrobial agents, strategic collaborations, partnerships and regulatory approvals, and progress in the medical pipeline.

Get your impetigo market report here!

https://www.thebusinessresearchcompany.com/report/impetigo-global-market-report

What main drivers are fueling expansion in the impetigo market?

The surge in skin infections is anticipated to boost the growth of the impetigo market. Skin infections denote scenarios where harmful microorganisms, such as bacteria, viruses, fungi, or parasites attack the skin, leading to reactions like inflammation and other symptoms. The increase in skin infections can be attributed to high levels of antibiotic resistance, lack of hygiene, climate change, weakened immune systems and global travel. Treatments for impetigo assist in managing the infection and accelerating healing by focusing on the bacterial assailants, usually Streptococcus or Staphylococcus species. This is often facilitated through oral or topical antibiotics which aid in offsetting symptoms such as itching and discomfort, and preventing reinfection. For instance, in September 2024, GOV.UK reported 13,912 cases of Staphylococcus aureus bacteremia in the 2022-2023 financial year, reflecting a 7.2% rise compared to the 2021-2022 fiscal year. This indicates the skin infection surge is positively affecting the impetigo market. The advancement in healthcare facilities is anticipated to encourage the impetigo market growth. Healthcare facilities, such as hospitals, clinics, and diagnostic centres, are improving due to factors like increased healthcare infrastructure investment, emphasis on patient-centred care, and growing population and aging. This advancement assists with impetigo management by enhancing access to specialist dermatological care, increasing treatment options, fostering better hygiene to prevent infections, and allowing early diagnosis and prompt treatment. For instance, in May 2023, the American Health Care Association revealed that there were 6,129 US hospitals, which represents a 0.591% increase from the previous year’s total of 6,093. Therefore, the improvement of healthcare facilities boosts the impetigo market.

What key areas define the segmentation of the global impetigo market?

The impetigo market covered in this report is segmented –

1) By Treatment Type: Topical Antibiotics, Oral Antibiotics, Antiseptic Soaks

2) By Causative Pathogen: Staphylococcus aureus, Streptococcus pyogenes, Other Bacteria

3) By Severity: Mild, Moderate, Severe

4) By Patient Age: Children, Adults, Elderly

Subsegments:

1) By Topical Antibiotics: Mupirocin, Retapamulin, Fusidic Acid

2) By Oral Antibiotics: Cephalexin, Dicloxacillin, Clindamycin

3) By Antiseptic Soaks: Chlorhexidine, Hydrogen Peroxide, Potassium Permanganate

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21209&type=smp

Who are the dominant players expanding their reach in the impetigo market?

Major companies operating in the impetigo market are Roche Holding AG, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Galderma SA, Shionogi & Co. Ltd., Dr. Reddy’s Laboratories Ltd., Leo Pharma A/S, Torrent Pharmaceuticals Ltd., Almirall S.A, Taro Pharmaceutical Industries Ltd., BioCryst Pharmaceuticals Inc., Melinta Therapeutics Inc., Cutanea Life Sciences Inc., InfectoPharm Arzneimittel und Consilium GmbH, Medimetriks Pharmaceuticals Inc., NovaBay Pharmaceuticals Inc., Ferrer Internacional S.A

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21209

Which regions are emerging as leaders in the impetigo market?

North America was the largest region in the impetigo market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the impetigo market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Influenza Diagnostic Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/influenza-diagnostic-global-market-report

Large Volume Parenteral LVP Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/influenza-vaccines-global-market-report

Prostate Specific Antigen (PSA) Test Global Market Report 2025

https://thebusinessresearchcompany.com/report/prostate-specific-antigen-psa-test-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: